Mary K. Nesline

SVP Clinical Evidence Development

As SVP of Clinical Evidence Development, Mary Nesline establishes and executes measurement strategies and studies that support clinical utility for the OmniSeq product portfolio, supports product reimbursement and distribution strategies, and leverages OmniSeq testing assets for external pharmaceutical and academic business development.

Prior to joining Omniseq, Mary played several roles at Roswell Park Cancer Institute (RPCI), including Director of Clinical Support Informatics for the Center for Personalized Medicine, and Co-Director of the Institute’s Data Bank and BioRepository and collaborating to develop shared translational research resources and infrastructure from the ground up. Mary earned a Master’s of Science degree in Epidemiology from the State University of New York at Buffalo, where she focused on implementing novel primary care service delivery and reimbursement models for vulnerable populations in the Department of Family Medicine.